Posted 20th February 2017 by Fabio Caligaris
Jim Huggett’s research focuses on molecular diagnostics, genomics and nucleic acids, including cancer and foetal genetic analysis and the diagnosis of infectious diseases. We interviewed him about the latest developments and the latest advances in qPCR research.
Posted 17th February 2017 by Jane Williams
President Jimmy Carter announced last spring that he no longer needed treatments for the metastatic melanoma found in his brain – after treatment with pembrolizumab (Keytruda, Merck), his physicians could no longer detect the cancer.
Posted 10th February 2017 by Jane Williams
Microfluidics technology has been applied and adopted across many areas of science and technology over the last 20 years, revolutionising the way patients are diagnosed, monitored and treated. Innovation remains very high in sample analysis and detection and progress has been boosted by the many new tools and procedures created in parallel to enable this.
Posted 8th February 2017 by Laura Berry
Dysbiotic characteristics are increasingly attributed to a range of serious, and sometimes fatal, digestive disorders affecting humans. These include inflammatory bowel diseases, chemotherapy-induced mucositis, radiation enteritis, NSAID-enteropathy and colon cancer.
Posted 3rd February 2017 by Laura Berry
The structure and function of the human gut microbiome is being revealed through culture-independent molecular techniques. Many studies have found a great deal of interpersonal variability due to factors such as diet, age and ethnicity. However, there are a small number of relatively abundant microbial species that appear to be widespread in the human population.
Posted 1st February 2017 by Jane Williams
Keith Kaplan is well known in the digital pathology circuit. A practising pathologist and author of the Digital Pathology Blog, he describes himself as an evangelist for the technology. We sat down with him at the Digital Pathology Congress, where he chaired a panel discussion, to get his thoughts.
Posted 30th January 2017 by Laura Berry
The Molecular Biology Summit hosted three meetings in parallel: the qPCR and Digital PCR Congress, the Microfluidics Congress, and the Synthetic Biology Congress. Each meeting had talks organised into tracks which took place side-by-side. I attended the Synthetic Biology Congress, which also gave me access to the other two meetings.
Posted 27th January 2017 by Jane Williams
Assays are crucial during pre-clinical and clinical trials, and for pharmacovigilance. By this stage, the molecule has already been fully profiled with a mechanism of action, and efficacy and safety are now being assessed in vivo.